FDA
-
-
-
-
-
-
-
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
-
-
-
-
-
-
-
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
-
-
-
-
-
-
-
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
-
-
-
-
-
-
-
Axonics, Inc. (AXNX) Announces Launch of the Axonics F15
-
-
-
-
-
-
-
BioVentrix Announces Raymond W. Cohen as Chairman of the Board and Newly Appointed Accredited Public Company Directors Rinda K. Sama and Andrew G. Hinson to Its Board of Directors
-
-
-
-
-
-
-
Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors
-
-
-
-
-
-
-
Axonics® Submits PMA Supplement to FDA to Further Expand MRI Labeling
-
251,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All